Inventor · disambiguated record
Corey Strickland
Also filed as: STRICKLAND COREY · STRICKLAND COREY O · STRICKLAND COREY OHMAN
37 granted patents·4 pending applications·312 citations·filing 1999–2023
97Inventor score
Top patents by PatentIndex Score
41 records- 0195US7763609B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2007·Granted Jul 27, 2010·38 cites·12 claims
- 0290US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 0390US7868000B2Aspartyl protease inhibitorsSCHERING CORP·Filed 2006·Granted Jan 11, 2011·18 cites·45 claims
- 0488US7700603B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2005·Granted Apr 20, 2010·9 cites·8 claims
- 0587US9181632B1C.difficile toxin B CROP domain peptides, antibodies and complexes thereofMERCK SHARP & DOHME·Filed 2014·Granted Nov 10, 2015·12 cites·4 claims
- 0687US6362188B1Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 1999·Granted Mar 26, 2002·85 cites·29 claims
- 0786US8829036B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Sep 9, 2014·7 cites·3 claims
- 0886US7973067B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2008·Granted Jul 5, 2011·6 cites·22 claims
- 0986US7910590B2Cyclic amine bace-1 inhibitors having a heterocyclic substituentSCHERING CORP·Filed 2009·Granted Mar 22, 2011·8 cites·31 claims
- 1085US8691831B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·18 claims
- 1185US8691833B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Apr 8, 2014·7 cites·9 claims
- 1285US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 1385US7569391B2Method for making β-secretase co-crystals complexed with a ligandSCHERING CORP·Filed 2006·Granted Aug 4, 2009·6 cites·1 claims
- 1484US7592348B2Heterocyclic aspartyl protease inhibitorsSCHERING CORP·Filed 2004·Granted Sep 22, 2009·16 cites·41 claims
- 1583US8012953B2Macrocyclic beta-secretase inhibitorsSCHERING CORP·Filed 2009·Granted Sep 6, 2011·5 cites·30 claims
- 1680US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 1780US7529628B2Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitorsSCHERING CORP·Filed 2006·Granted May 5, 2009·2 cites·4 claims
- 1879US7138264B1Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2003·Granted Nov 21, 2006·3 cites·11 claims
- 1977US8242112B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2011·Granted Aug 14, 2012·2 cites·4 claims
- 2075US7824897B2Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2010·Granted Nov 2, 2010·1 cites·6 claims
- 2174US8178513B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2009·Granted May 15, 2012·1 cites·13 claims
- 2272US9062007B2Cyclic amide BACE-1 inhibitors having a benzamide substituentPHARMACOPEIA DRUG DISCOVERY·Filed 2014·Granted Jun 23, 2015·1 cites·6 claims
- 2372US7598250B2Cyclic amine BACE-1 inhibitors having a heterocyclic substituentSCHERING CORP·Filed 2004·Granted Oct 6, 2009·5 cites·34 claims
- 2472US6645966B2Treatment of malaria with farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2002·Granted Nov 11, 2003·5 cites·9 claims
- 2570US7700753B2Modified tumor necrosis factor-alpha converting enzyme and methods of use thereofSCHERING CORP·Filed 2009·Granted Apr 20, 2010·0 cites·8 claims
- 2669US8623867B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2012·Granted Jan 7, 2014·1 cites·8 claims
- 2766US11014986B2Crystals of anti-human PD-1 monoclonal antibodiesREICHERT PAUL·Filed 2016·Granted May 25, 2021·1 cites·18 claims
- 2866US8063185B2Refolded recombinant β-secretase crystals and methods for preparing and using the sameBEYER BRIAN M·Filed 2009·Granted Nov 22, 2011·0 cites·8 claims
- 2966US8034907B2Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptidesSCHERING CORP·Filed 2009·Granted Oct 11, 2011·0 cites·7 claims
- 3063US7705127B1HDM2 PolypeptidesSCHERING CORP·Filed 2008·Granted Apr 27, 2010·0 cites·8 claims
- 3163US7166454B1Codon-optimized β-secretase and methods of refolding and processingSCHERING CORP·Filed 2003·Granted Jan 23, 2007·0 cites·20 claims
- 3261US8778980B2Heterocyclic aspartyl protease inhibitorsZHU ZHAONING·Filed 2012·Granted Jul 15, 2014·0 cites·15 claims
- 3360US2024426832A1Methods of identifying compounds for inducing protein-protein interactionONCOPIA THERAPEUTICS INC D/B/A/ SK LIFE SCIENCE LABS·Filed 2023·Application pending·0 cites
- 3459US6535820B1Crystalline farnesyl protein transferase compositions and methods for useSCHERING CORP·Filed 1999·Granted Mar 18, 2003·7 cites·12 claims
- 3558US7632920B2Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereofSCHERING CORP·Filed 2004·Granted Dec 15, 2009·0 cites·10 claims
- 3658US6800636B2Farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2001·Granted Oct 5, 2004·1 cites·8 claims
- 3758US2004014194A1Beta-secretase crystals and methods for preparing and using the sameSCHERING CORP·Filed 2003·Application pending·0 cites
- 3852US7888474B2HDM2 polypeptidesSCHERING CORP·Filed 2010·Granted Feb 15, 2011·0 cites·8 claims
- 3951US6539309B1Crystallizable farnesyl protein transferase compositions, crystals thereby obtained, and methods for useSCHERING CORP·Filed 1999·Granted Mar 25, 2003·8 cites·4 claims
- 4050US2004087592A1Treatment of malaria with farnesyl protein transferase inhibitorsFiled 2003·Application pending·0 cites
- 4148US2003134846A1Treatment of trypanosoma brucei with farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Corey Strickland files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →